Humacyte Correlations

HUMA Stock

USD 4.43 0.15 3.50%

The current 90-days correlation between Humacyte and Icosavax is 0.11 (i.e., Average diversification). The correlation of Humacyte is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Humacyte Correlation With Market

Very good diversification

The correlation between Humacyte and DJI is -0.23 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Humacyte and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humacyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Humacyte Stock refer to our How to Trade Humacyte Stock guide.

Moving together with Humacyte Stock

0.76	DNTH	Dianthus Therapeutics	Pair Corr
0.62	VERU	Veru Inc Fiscal Year End 13th of December 2024	Pair Corr
0.73	VIRX	Viracta Therapeutics	Pair Corr
0.69	DWTX	Dogwood Therapeutics, Symbol Change	Pair Corr
0.73	VTGN	VistaGen Therapeutics	Pair Corr

Moving against Humacyte Stock

0.67	VCYT	Veracyte Buyout Trend	Pair Corr
0.57	VCEL	Vericel Corp Ord	Pair Corr
0.54	VANI	Vivani Medical	Pair Corr
0.47	VERA	Vera Therapeutics	Pair Corr
0.41	DRTS	Alpha Tau Medical	Pair Corr
0.32	DSGN	Design Therapeutics Upward Rally	Pair Corr
0.32	SABSW	SAB Biotherapeutics	Pair Corr
0.56	VRNA	Verona Pharma PLC	Pair Corr
0.54	VSTM	Verastem	Pair Corr
0.52	DYAI	Dyadic International	Pair Corr
0.36	VTVT	vTv Therapeutics	Pair Corr

Related Correlations Analysis

	CRNX	VRDN	CYTK	GPCR	ICVX	IMCR	MIRM	LRMR	KALV	LYRA
CRNX		0.47	0.02	-0.32	0.44	0.29	0.27	0.45	0.05	-0.21	CRNX
VRDN	0.47		0.0	0.3	0.71	-0.4	-0.33	-0.01	-0.13	-0.25	VRDN
CYTK	0.02	0.0		0.31	-0.23	0.49	-0.14	0.49	0.49	0.5	CYTK
GPCR	-0.32	0.3	0.31		0.09	-0.29	-0.64	0.04	0.29	0.52	GPCR
ICVX	0.44	0.71	-0.23	0.09		-0.48	-0.26	-0.01	-0.14	-0.42	ICVX
IMCR	0.29	-0.4	0.49	-0.29	-0.48		0.32	0.55	0.43	0.44	IMCR
MIRM	0.27	-0.33	-0.14	-0.64	-0.26	0.32		-0.06	-0.32	-0.4	MIRM
LRMR	0.45	-0.01	0.49	0.04	-0.01	0.55	-0.06		0.49	0.48	LRMR
KALV	0.05	-0.13	0.49	0.29	-0.14	0.43	-0.32	0.49		0.57	KALV
LYRA	-0.21	-0.25	0.5	0.52	-0.42	0.44	-0.4	0.48	0.57		LYRA
	CRNX	VRDN	CYTK	GPCR	ICVX	IMCR	MIRM	LRMR	KALV	LYRA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ICVX	+ 0.71	VRDN
LYRA	+ 0.57	KALV
LRMR	+ 0.55	IMCR
LYRA	+ 0.52	GPCR
LYRA	+ 0.5	CYTK
IMCR	+ 0.49	CYTK

High negative correlations

MIRM	- 0.64	GPCR
IMCR	- 0.48	ICVX
LYRA	- 0.42	ICVX
LYRA	- 0.4	MIRM
IMCR	- 0.4	VRDN
MIRM	- 0.33	VRDN

Risk-Adjusted Indicators

There is a big difference between Humacyte Stock performing well and Humacyte Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Humacyte's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CRNX	1.68	0.16	0.01	(0.69)	2.43	(1.60)	3.67	(3.45)	16.75
VRDN	3.27	0.64	0.15	1.14	3.43	(3.84)	6.84	(5.29)	44.89
CYTK	1.92	(0.12)	0.00	2.38	0.00	0.00	3.52	(4.15)	14.08
GPCR	2.92	(0.15)	0.00	(0.49)	0.00	0.00	8.18	(6.07)	24.50
ICVX	4.87	1.33	0.17	(0.37)	4.56	(5.67)	10.22	(6.79)	38.57
IMCR	1.95	(0.10)	0.00	(0.48)	0.00	0.00	3.54	(3.87)	10.78
MIRM	1.71	0.16	0.00	(0.52)	2.24	(1.85)	3.88	(4.18)	12.25
LRMR	4.13	(0.41)	0.00	(0.22)	0.00	0.00	10.87	(9.55)	26.71
KALV	3.36	(0.31)	0.00	11.25	0.00	0.00	6.50	(6.22)	31.70
LYRA	4.14	(0.70)	0.00	(0.37)	0.00	0.00	8.00	(10.00)	41.07

Humacyte Corporate Management

Harold Alterson	Senior Quality	Profile
Sabrina Osborne	Executive People	Profile
Dale Sander	Chief CFO	Profile
William Scheessele	Chief Officer	Profile
Yang MD	Chief Officer	Profile
Shamik MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC